• References

    Bonnema SJ, Bennedbek FN, et al. Management of the nontoxic multinodular goiter: a North American Survey.
    J Clin Endocrinol Metab. 2002;87:112-117.

    Bonnema SJ, Nielsen VE, et al. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trail.
    J Clin Endo Metab.

    Diehl LA, Garcia V, Bonnema SJ, et al. Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey.
    J Clin Endocrinol Metab. 2005;90:117-123.

    Freitas JE. Therapeutic options in the management of toxic and nontoxic nodular goiter.
    Seminars in Nuclear Medicine. 2000;30:88-97.

    Hurley DL, Gharib H. Evaluation and management of multinodular goiter.
    Otolaryngol Clin North Am. 1996;29:527-540.

    Kasper DL, et al.
    Harrison’s Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005.

  • Resources

    American Association of Clinical Endocrinologists

    The American Thyroid Association

    The Hormone Foundation

    Thyroid Foundation of America

  • Canadian Resources

    Canadian Family Physician

    Thyroid Foundation of Canada